Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 405 - Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
Patents for C07D 405 - Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom (69,397)
12/2005
12/01/2005WO2005060963A8 Benzenesulfonylamino-pyridin-2-yl derivatives and related compounds as inhibitors of 11-beta-hydroxysteroid dehydrogenase type 1 (11-beta-hsd-1) for the treatment of diabetes and obesity
12/01/2005WO2004101544A8 Benzyl sulfonamide derivatives as androgen receptor antagonists
12/01/2005WO2004089894A8 Process for preparing 5-(4-fluorophenyl)-1-[2-((2r,4r)-4-hydroxy-6-oxo-tetrahydro-pyran-2-yl)ethyl]-2-isopropyl-4-phenyl-1h-pyrrole-3-carboxylic acid phenylamide
12/01/2005WO2004085401A8 1,2,4-substituted 1,2,3,4-tetrahydro-and 1,2 dihydro-quinoline and 1,2,3,4-tetrahydro-quinoxaline derivatives as cetp inhibitors for the treatment of atherosclerosis and obesity
12/01/2005US20050267199 2-Amino- and 2-thio- substituted 1,3-diaminopropanes
12/01/2005US20050267198 Novel processes for preparing amorphous atorvastatin hemi-calcium
12/01/2005US20050267194 Indole compounds
12/01/2005US20050267188 Benzopyran derivatives substituted with secondary amines including imidazole, their preparation and pharmaceutical compositions containing them
12/01/2005US20050267186 Minimal cardivascular and/or sedatory activity; treating pain and allodynia; selective to alpha2B and/or alpha2C adrenergic receptors in preference over alpha2A adrenergic receptors;
12/01/2005US20050267185 1,2,4-triazole derivatives, compositions, process of making and methods of use
12/01/2005US20050267182 Urea derivatives as FLT-3 modulators
12/01/2005US20050267171 Alpha-and beta-amino acid hydroxyethylamino sulfonamides useful as retroviral protease inhibitors
12/01/2005US20050267163 Vanilloid receptor ligands and their use in treatments
12/01/2005US20050267155 Constrained himbacine analogs as thrombin receptor antagonists
12/01/2005US20050267152 Gly1 transporter inhibitors and uses thereof in treatment of neurological and neuropsychiatric disorders
12/01/2005US20050267148 Benzimidazole derivative
12/01/2005US20050267147 Novel benzimidazole and imidazopyridine derivatives and use thereof as a medicament
12/01/2005US20050267142 Adenosine A2a receptors antagonist; 9H-indeno[2,1-c]pyridine-4-carboxylic acid, 3-amino-1-furan-2-yl-9-oxo-, 2-dimethylamino-ethyl ester; neurodegenerative and movement disease, as Parkinson's; improves binding affinity of Dopamine D2 agonist to their receptors
12/01/2005US20050267139 Arylindenopyridines and arylindenopyrimidines and related therapeutic and prophylactic methods
12/01/2005US20050267138 Arylindenopyridines and arylindenopyrimidines and related therapeutic and prophylactic methods
12/01/2005US20050267137 Cyclopropane CGRP antagonists, medicaments containing these compounds, and method for the production thereof
12/01/2005US20050267122 Ansamycins having improved pharmacological and biological properties
12/01/2005US20050267119 Urea antagonists of P2Y1 receptor useful in the treatment of thrombotic conditions
12/01/2005US20050267115 Melanin-concentrating hormone (MCH); for the treatment of metabolic disorders and/or eating disorders, such as obesity and diabetes, also drug dependencies, and urinary incontinence
12/01/2005US20050267111 Pharmaceutical compositions and methods for use
12/01/2005US20050267110 Propane-1, 3-dione derivative
12/01/2005US20050267108 Treatment of peroxisome proliferation activated receptor diseases such as diabetes, skin disorders or high blood pressure
12/01/2005US20050267098 Modulators of cellular adhesion
12/01/2005US20050267089 (5-Methoxy-2-pyridin-2-yl-pyrimidin-4-yl)-(5-pyrrolidin-1-yl-pyridin-2-yl)-amine; SK channel modulators (SK=small conductance calcium activated potassium channels); antiepileptic agents; seizures; learning enhancement; cognition activators; mood/psychotic disorders; antidepressants; Parkinson's disease
12/01/2005US20050267073 Triheterocyclic compounds, compositions, and methods for treating cancer or viral diseases
12/01/2005US20050267043 Novel inhibitors of hepatitis C virus NS3 protease
12/01/2005US20050266453 Mutagenesis methods using ribavirin and/or RNA replicases
12/01/2005CA2567483A1 Pyrazinylmethyl lactam derivatives
12/01/2005CA2567404A1 Cyclopenta[b]benzofuran derivatives and the utilization thereof
12/01/2005CA2567352A1 5-anilino-4-heteroarylpyrazole derivatives useful for the treatment of diabetes
12/01/2005CA2567343A1 N-cyclic sulfonamido inhibitors of gamma secretase
12/01/2005CA2566934A1 Tetrahydronaphthyl- piperazines as 5-ht1b antagonists, inverse agonists and partial agonists
12/01/2005CA2566460A1 Quinoxalin-2-one derivatives crop protection agents comprising the same and method for production and use thereof
12/01/2005CA2566387A1 Aryl sulfonamides as chemokine receptor ccr9 antagonists
12/01/2005CA2565200A1 Raf modulators and methods of use
12/01/2005CA2564076A1 Chemical linkers and conjugates thereof
12/01/2005CA2563968A1 Neurogenic pain control agent composition
11/2005
11/30/2005EP1600448A2 Enantiomerically pure beta-D-(-)-Dioxolane-Nucleosides
11/30/2005EP1600442A1 Heteroarylcarbamoylbenzene derivative
11/30/2005EP1599470A1 Antibacterial indolone oxazolidinones, intermediates for their preparation and pharmaceutical compositions containing them
11/30/2005EP1599468A1 1,2,3-trisubstituted aryl and heteroaryl derivatives as modulators of metabolism and the prophylaxis and treatment of disorders related thereto such as diabetes and hyperglycemia
11/30/2005EP1599467A1 Novel cyanopyridine derivatives useful in the treatment of cancer and other disorders
11/30/2005EP1599451A1 Pesticidal 1-ayl-3-amidoxime-pyrazole derivatives
11/30/2005EP1599167A2 Novel benzimidazole and imidazopyridine derivatives and use thereof as a medicament
11/30/2005EP1599096A2 Hetero substitued sodium channel blockers
11/30/2005EP1483246B1 5-substituted-alkylaminopyrazole derivatives as pesticides
11/30/2005EP1458381B1 Triazoles as oxytocin antagonists
11/30/2005EP1212314B1 Benzopyran derivative
11/30/2005EP1091943B1 Non-peptidyl inhibitors of vla-4 dependent cell binding useful in treating inflammatory, autoimmune, and respiratory diseases
11/30/2005EP0932403B1 Condensed (hetaryl-substituted) 1-benzyl-3-pyrazol derivates for treating diseases of the cardiovascular and central nervous systems
11/30/2005EP0925291B1 Spirocyclic dopamine receptor subtype ligands
11/30/2005EP0920424B1 Non-peptide bombesin receptor antagonists
11/30/2005EP0888341B1 Novel sulphur derivatives comprising an amide bond, method for preparing same, use thereof as drugs, and pharmaceutical compositions containing such derivatives
11/30/2005CN1703412A Novel compounds with antibacterial activity
11/30/2005CN1703411A Piperidine derivatives as CCR5 inhibitors
11/30/2005CN1703410A Isoquinoline compounds and medicinal use thereof
11/30/2005CN1703403A Metabotropic glutamate receptor antagonists
11/30/2005CN1703402A Pyridine derivatives as CB2 receptor modulators
11/30/2005CN1703400A Substituted 1,4-di-piperidin-4-yl-piperazine derivatives and their use as neurokinin antagonists
11/30/2005CN1229377C Spiro [Piperidine-4,1'-pyrrolo[3,4-c] pyrrole]
11/30/2005CN1229370C Novel derivatives of flavones, xanthones and coumarins
11/30/2005CN1229368C Phenyl-substituted 5,6-dihydropyrone derivatives for use as pesticides and herbicides
11/30/2005CN1229354C Acyl mercapto-triazolyl derivative and use thereof as microbiocides
11/30/2005CN1229353C Method and compositions utilizing quinazolinones
11/30/2005CN1229350C New azabicyclooctane derivatives useful in the treatment of cardiac arrhythmias
11/30/2005CN1229349C Pyridine-3-carboxylic acid derivative
11/30/2005CN1229336C Photoactive compound used as intermediate for preparing photoactive 2-imidazoline-5-ketone or 2-imdazoline-5-thio-ketone derivative
11/30/2005CN1229323C Dialkoyl-halogen phenyl substituted keto-enol
11/29/2005US6969770 reacting an alpha-keto carboxy acid ester or derivative with a pyrrolidinone to form an intermediate, subjecting the intermediate to asymmetric hydrogenation using a chiral catalyst to form the end product
11/29/2005US6969766 PNA monomer and precursor
11/29/2005US6969730 Amines as histamine-3 receptor ligands and their therapeutic applications
11/29/2005US6969728 Antiinflammatory agents
11/29/2005US6969727 Obesity; osteoporosis
11/29/2005US6969723 preferably antagonists used in the therapeutic and/or preventive treatment of disfunctions of the heart, kidney, respiratory system, central nervous system
11/29/2005US6969714 Imidazolo-5-YL-2-anilino-pyrimidines as agents for the inhibition of the cell proliferation
11/29/2005CA2420329C Sulphonylaminocarbonyltriazolinones
11/29/2005CA2332513C New derivatives of 4-sulfonamide piperidine, preparation process thereof and the pharmaceutical compositions they contain
11/29/2005CA2244245C Dihydrobenzofuran and related compounds useful as anti-inflammatory agents
11/29/2005CA2081068C Antiviral 4-substituted-2-deoxy-2,3-didehydro-derivatives of .alpha.-d-neuraminic acid
11/24/2005WO2005111042A1 Novel indole derivatives as selective androgen receptor modulators (sarms)
11/24/2005WO2005111030A1 Quinolone antibacterial agents
11/24/2005WO2005111027A1 Novel method of synthesising 1,3,4,5-tetrahydro-2h-3-benzazepin-2-one derivatives and use thereof in the synthesis of ivabradine and the salts thereof for addition to a pharmaceutically acceptable acid
11/24/2005WO2005111026A1 Novel method of synthesising 1,3-dihydro-2h-3-benzazepin-2-one derivatives and use thereof in the synthesis of ivabradine and the salts thereof for addition to a pharmaceutically acceptable acid
11/24/2005WO2005111025A1 3-piperidinylisochroman-5-ols as dopamine agonists
11/24/2005WO2005111023A1 Pyrimidine derivatives for the treatment of abnormal cell growth
11/24/2005WO2005111020A2 Pyrimidine hydantoin analogues which inhibit leukocyte adhesion mediated by vla-4
11/24/2005WO2005111017A1 Triazine compounds as inhibitors of bacterial type iii protein secretion systems
11/24/2005WO2005111003A1 Amino-tetrazoles analogues and methods of use
11/24/2005WO2005110994A2 Substituted pyrazolyl urea derivatives useful in the treatment of cancer
11/24/2005WO2005110992A1 Amido compounds and their use as pharmaceuticals
11/24/2005WO2005110991A1 1-aryl-4-substituted isoquinolines
11/24/2005WO2005110988A1 Pyridone compounds as inhibitors of bacterial type iii protein secretion systems
11/24/2005WO2005110987A1 Piperidine derivatives as nk1 and nk3 antagonists
11/24/2005WO2005110416A2 4,5-disubstituted-2-aryl pyrimidines
11/24/2005WO2005110409A2 Tetrahydropyranyl cyclopentyl 1-substituted and 1,1-disubstituted tetrahydroisoquinoline modulators of chemokine receptor activity
1 ... 281 282 283 284 285 286 287 288 289 290 291 292 293 294 295 296 297 298 299 300 301 ... 694